White Pine Capital’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,700
| Closed | -$28K | – | 216 |
|
|
2020
Q1 | $28K | Sell |
12,700
-2,800
| -18% | -$6.17K | 0.01% | 202 |
|
|
2019
Q4 | $47K | Hold |
15,500
| – | – | 0.02% | 217 |
|
|
2019
Q3 | $48K | Hold |
15,500
| – | – | 0.02% | 226 |
|
|
2019
Q2 | $31K | Hold |
15,500
| – | – | 0.01% | 225 |
|
|
2019
Q1 | $67K | Hold |
15,500
| – | – | 0.02% | 218 |
|
|
2018
Q4 | $49K | Sell |
15,500
-2,600
| -14% | -$8.22K | 0.02% | 209 |
|
|
2018
Q3 | $95K | Hold |
18,100
| – | – | 0.03% | 222 |
|
|
2018
Q2 | $97K | Sell |
18,100
-10,100
| -36% | -$54.1K | 0.03% | 228 |
|
|
2018
Q1 | $141K | Hold |
28,200
| – | – | 0.05% | 226 |
|
|
2017
Q4 | $93K | Hold |
28,200
| – | – | 0.03% | 212 |
|
|
2017
Q3 | $106 | Hold |
28,200
| – | – | ﹤0.01% | 212 |
|
|
2017
Q2 | $72K | Hold |
28,200
| – | – | 0.03% | 214 |
|
|
2017
Q1 | $73K | Buy |
+28,200
| New | +$73K | 0.03% | 206 |
|